CIBC Private Wealth Group
IGC icon

CIBC Private Wealth Group’s IGC Pharma IGC Stock Holding History

CIBC Private Wealth Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$184 Hold
655
– – ﹤0.01% 3233
2025
Q3 		$273 Hold
655
– – ﹤0.01% 2922
2025
Q2 		$200 Hold
655
– – ﹤0.01% 2916
2025
Q1 		$177 Hold
655
– – ﹤0.01% 2961
2024
Q4 		$217 Hold
655
– – ﹤0.01% 2886
2024
Q3 		$280 Hold
655
– – ﹤0.01% 3011
2024
Q2 		$270 Hold
655
– – ﹤0.01% 3032
2024
Q1 		$312 Buy
+655
New +$203 ﹤0.01% 2964

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

CIBC Private Wealth Group's IGC Position: Q4 2025 in Review

CIBC Private Wealth Group held its IGC Pharma (IGC) position steady in Q4 2025 at 655 shares worth $184. The position accounts for ﹤0.01% of the portfolio, ranked #3233.

CIBC Private Wealth Group first reported a position in IGC in Q1 2024 and has held it in 8 quarters since. The position peaked at $312 in Q1 2024. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • CIBC Private Wealth Group held 655 shares of IGC Pharma worth $184 as of Q4 2025.
  • CIBC Private Wealth Group left its IGC Pharma share count unchanged in Q4 2025.
  • IGC Pharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3233 holding.
  • CIBC Private Wealth Group first reported a position in IGC Pharma in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's IGC Pharma position peaked at $312 in Q1 2024.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.